Answers are grounded in this paper and cite their sources.
Diagnosis and treatment of leptomeningeal metastases (LM) in epidermal growth factor receptor mutation-positive (EGFRm +) non-small-cell lung carcinoma (NSCLC) is challenging. We aimed to identify resistance mechanisms (RM) to osimertinib in cerebrospinal fluid (CSF) and plasma.
No takes yet. Share an insight, caveat, or question.
Wel et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: